Weighted Average Number of Shares Outstanding, Basic of Maze Therapeutics, Inc. from 31 Mar 2024 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: shares
- Description
- Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
- Summary
-
Maze Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2024 to 31 Dec 2025.
- Maze Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 42,976,024, a 1694% increase year-over-year.
- Maze Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 42,976,024, a 1694% increase from 2024.
- Source SEC data
- View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)
Maze Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 42,976,024 | +40,579,930 | +1694% | 01 Oct 2025 | 31 Dec 2025 | 10-K | 25 Mar 2026 | 2025 | FY | |
| Q3 2025 | 45,779,577 | +43,363,680 | +1795% | 01 Jul 2025 | 30 Sep 2025 | 10-Q | 06 Nov 2025 | 2025 | Q3 | |
| Q2 2025 | 43,797,421 | +41,408,302 | +1733% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 12 Aug 2025 | 2025 | Q2 | |
| Q1 2025 | 28,628,430 | +26,291,817 | +1125% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 14 May 2025 | 2025 | Q1 | |
| Q4 2024 | 2,396,094 | 01 Oct 2024 | 31 Dec 2024 | 10-K | 25 Mar 2026 | 2025 | FY | |||
| Q3 2024 | 2,415,897 | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 06 Nov 2025 | 2025 | Q3 | |||
| Q2 2024 | 2,389,119 | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 12 Aug 2025 | 2025 | Q2 | |||
| Q1 2024 | 2,336,613 | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 14 May 2025 | 2025 | Q1 |
Maze Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | 42,976,024 | +40,579,930 | +1694% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 25 Mar 2026 | 2025 | FY |
| 2024 | 2,396,094 | 01 Jan 2024 | 31 Dec 2024 | 10-K | 25 Mar 2026 | 2025 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.